« Back to Record
Citation APA

Bregni, G., Sticca, T., Camera, S., Akin Telli, T., Craciun, L., Trevisi, E., Pretta, A., Kehagias, P., Leduc, S., Senti, C., Deleporte, A., Vandeputte, C., Saad, E. D., Kerger, J., Gil, T., Piccart-Gebhart, M., Awada, A., Demetter, P., Larsimont, D., Hendlisz, A., Aftimos, P., & Sclafani, F. (2020). Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel. Acta oncologica, 59(12), 1438-1446. doi:10.1080/0284186X.2020.1809704


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/348634

Bregni, G., Sticca, T., Camera, S., Akin Telli, T., Craciun, L., Trevisi, E., Pretta, A., Kehagias, P., Leduc, S., Senti, C., Deleporte, A., Vandeputte, C., Saad, E. D., Kerger, J., Gil, T., Piccart-Gebhart, M., Awada, A., Demetter, P., Larsimont, D., Hendlisz, A., Aftimos, P., & Sclafani, F. (2020). Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel. Acta oncologica, 59(12), 1438-1446. doi:10.1080/0284186X.2020.1809704